Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01849887
Recruitment Status : Withdrawn (Study was never started)
First Posted : May 9, 2013
Last Update Posted : January 22, 2016
Sponsor:
Information provided by (Responsible Party):
Steven C. Cramer, MD, University of California, Irvine

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : January 2016
Actual Study Completion Date : January 2016